Login / Signup

Evaluating availability and price of essential medicines in Boston area (Massachusetts, USA) using WHO/HAI methodology.

Abhishek SharmaLindsey RordenMargaret EwenRichard Laing
Published in: Journal of pharmaceutical policy and practice (2016)
While noting the WHO target that consumers should pay no more than four times the IRPs, medicine prices were considerably higher in the Boston area. The prices for medicines included in the pharmacy discount programs were closest to WHO's target. Consumers should shop around, as medicine inclusion and prices vary across discount programs. In order for consumers to identify meaningful potential savings through comparison shopping, price transparency is needed.
Keyphrases
  • public health
  • health insurance
  • human health
  • risk assessment
  • climate change
  • clinical evaluation